Press release
Anti-Infective Vaccines Market Growth, Trends, Share, COVID-19 Analysis and Forecast 2021-2028
The worldwide Anti-Infective Vaccines market report is the very much investigated answer for the chiefs and academicians who are looking for a definite examination regarding both subjective just as quantitative, for the notable time frame and for the impending years gauge. The exploration report includes the business outline alongside the approaching dangers and supporting components that will drive or hamper the market development and give open doors sooner rather than later.DOWNLOAD FREE SAMPLE STUDY PDF (INCLUDING FULL TOC, TABLE & FIGURES) @ https://www.amecoresearch.com/sample/271736
The Anti-Infective Vaccines market is finely sectioned by thinking about the most significant and responsive parts of the individual market. Furthermore, the fragments are all around examined for each topographical district including United States, European Union, China, Japan, India, Korea, and Southeast Asia. The significant nations are covered with nitty gritty data.
In particular, the effect of the COVID-19 pandemic that has disturbed the worldwide market as far as the production network, cash stream, and generally market financial matters is completely covered by remembering subjective and quantitative methodologies for the last report.
Aside from the division, the statistical surveying report includes set up essential devices (Value Chain Analysis, Supply Channel Analysis, Porter's five powers model, and others) that help people in simple arrangement and dissecting the general data in a more thorough and precise way.
By the product type, the market is primarily split into
Inactivated Vaccines
Conjugate Vaccines
Live/attenuated Vaccines
By the end users/application, this report covers the following segments
Bacterial Diseases
Viral Diseases
The Anti-Infective Vaccines key manufacturers in this market include:
Emergent BioDefense Operations Lansing Inc.
Sanofi Pasteur
Merck & Co.
MedImmune LLC
Novartis Vaccines
Diagnostics Ltd.
Intercell Biomedical
MassBiologics
Barr Labs, Inc.
Organon Teknika Co.
GlaxoSmithKline Biologicals
CSL Ltd.
ID Biomedical Co.
Protein Sciences Co.
Wyeth Pharmaceuticals, Inc.
Berna Biotech
CUSTOMIZED REQUIREMENTS? NEED ANY HELP? PLEASE EMAIL US AT@ sales@amecoresearch.com
The greater part of the top significant players are being shrouded in the examination report alongside their item contributions, income commitment, provincial presence, key turns of events, and business strength.
Report Link @ https://www.amecoresearch.com/market-report/global-anti-infective-vaccines-market-forecast-2028-271736
TABLE OF CONTENT:
1 Anti-Infective Vaccines Market Overview
1.1 Anti-Infective Vaccines Product Overview
1.2 Anti-Infective Vaccines Market Segment by Type
1.2.1 Inactivated Vaccines
1.2.2 Conjugate Vaccines
1.2.3 Live/attenuated Vaccines
1.3 Global Anti-Infective Vaccines Market Size by Type
1.3.1 Global Anti-Infective Vaccines Market Size Overview by Type (2016-2027)
1.3.2 Global Anti-Infective Vaccines Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global Anti-Infective Vaccines Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global Anti-Infective Vaccines Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global Anti-Infective Vaccines Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Anti-Infective Vaccines Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Anti-Infective Vaccines Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Anti-Infective Vaccines Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Anti-Infective Vaccines Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Anti-Infective Vaccines Sales Breakdown by Type (2016-2021)
1.4.2 Europe Anti-Infective Vaccines Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Anti-Infective Vaccines Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Anti-Infective Vaccines Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Anti-Infective Vaccines Sales Breakdown by Type (2016-2021)
2 Global Anti-Infective Vaccines Market Competition by Company
2.1 Global Top Players by Anti-Infective Vaccines Sales (2016-2021)
2.2 Global Top Players by Anti-Infective Vaccines Revenue (2016-2021)
2.3 Global Top Players Anti-Infective Vaccines Price (2016-2021)
2.4 Global Top Manufacturers Anti-Infective Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 Anti-Infective Vaccines Market Competitive Situation and Trends
2.5.1 Anti-Infective Vaccines Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Anti-Infective Vaccines Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-Infective Vaccines as of 2020)
2.7 Date of Key Manufacturers Enter into Anti-Infective Vaccines Market
2.8 Key Manufacturers Anti-Infective Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Anti-Infective Vaccines Status and Outlook by Region
3.1 Global Anti-Infective Vaccines Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Anti-Infective Vaccines Historic Market Size by Region
3.2.1 Global Anti-Infective Vaccines Sales in Volume by Region (2016-2021)
3.2.2 Global Anti-Infective Vaccines Sales in Value by Region (2016-2021)
3.2.3 Global Anti-Infective Vaccines Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Anti-Infective Vaccines Forecasted Market Size by Region
3.3.1 Global Anti-Infective Vaccines Sales in Volume by Region (2022-2027)
3.3.2 Global Anti-Infective Vaccines Sales in Value by Region (2022-2027)
3.3.3 Global Anti-Infective Vaccines Sales (Volume & Value), Price and Gross Margin (2022-2027)
4 Global Anti-Infective Vaccines by Application
4.1 Anti-Infective Vaccines Market Segment by Application
4.1.1 Bacterial Diseases
4.1.2 Viral Diseases
4.2 Global Anti-Infective Vaccines Market Size by Application
4.2.1 Global Anti-Infective Vaccines Market Size Overview by Application (2016-2027)
4.2.2 Global Anti-Infective Vaccines Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global Anti-Infective Vaccines Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global Anti-Infective Vaccines Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global Anti-Infective Vaccines Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Anti-Infective Vaccines Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Anti-Infective Vaccines Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Anti-Infective Vaccines Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Anti-Infective Vaccines Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Anti-Infective Vaccines Sales Breakdown by Application (2016-2021)
4.3.2 Europe Anti-Infective Vaccines Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Anti-Infective Vaccines Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Anti-Infective Vaccines Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Anti-Infective Vaccines Sales Breakdown by Application (2016-2021)
5 North America Anti-Infective Vaccines by Country
5.1 North America Anti-Infective Vaccines Historic Market Size by Country
5.1.1 North America Anti-Infective Vaccines Sales in Volume by Country (2016-2021)
5.1.2 North America Anti-Infective Vaccines Sales in Value by Country (2016-2021)
5.2 North America Anti-Infective Vaccines Forecasted Market Size by Country
5.2.1 North America Anti-Infective Vaccines Sales in Volume by Country (2022-2027)
5.2.2 North America Anti-Infective Vaccines Sales in Value by Country (2022-2027)
6 Europe Anti-Infective Vaccines by Country
6.1 Europe Anti-Infective Vaccines Historic Market Size by Country
6.1.1 Europe Anti-Infective Vaccines Sales in Volume by Country (2016-2021)
6.1.2 Europe Anti-Infective Vaccines Sales in Value by Country (2016-2021)
6.2 Europe Anti-Infective Vaccines Forecasted Market Size by Country
6.2.1 Europe Anti-Infective Vaccines Sales in Volume by Country (2022-2027)
6.2.2 Europe Anti-Infective Vaccines Sales in Value by Country (2022-2027)
7 Asia-Pacific Anti-Infective Vaccines by Region
7.1 Asia-Pacific Anti-Infective Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific Anti-Infective Vaccines Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Anti-Infective Vaccines Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Anti-Infective Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific Anti-Infective Vaccines Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Anti-Infective Vaccines Sales in Value by Region (2022-2027)
8 Latin America Anti-Infective Vaccines by Country
8.1 Latin America Anti-Infective Vaccines Historic Market Size by Country
8.1.1 Latin America Anti-Infective Vaccines Sales in Volume by Country (2016-2021)
8.1.2 Latin America Anti-Infective Vaccines Sales in Value by Country (2016-2021)
8.2 Latin America Anti-Infective Vaccines Forecasted Market Size by Country
8.2.1 Latin America Anti-Infective Vaccines Sales in Volume by Country (2022-2027)
8.2.2 Latin America Anti-Infective Vaccines Sales in Value by Country (2022-2027)
9 Middle East and Africa Anti-Infective Vaccines by Country
9.1 Middle East and Africa Anti-Infective Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa Anti-Infective Vaccines Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Anti-Infective Vaccines Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Anti-Infective Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa Anti-Infective Vaccines Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Anti-Infective Vaccines Sales in Value by Country (2022-2027)
10 Company Profiles and Key Figures in Anti-Infective Vaccines Business
10.1 Emergent BioDefense Operations Lansing Inc.
10.1.1 Emergent BioDefense Operations Lansing Inc. Corporation Information
10.1.2 Emergent BioDefense Operations Lansing Inc. Introduction and Business Overview
10.1.3 Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.1.4 Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Products Offered
10.1.5 Emergent BioDefense Operations Lansing Inc. Recent Development
10.2 Sanofi Pasteur
10.2.1 Sanofi Pasteur Corporation Information
10.2.2 Sanofi Pasteur Introduction and Business Overview
10.2.3 Sanofi Pasteur Anti-Infective Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.2.4 Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Products Offered
10.2.5 Sanofi Pasteur Recent Development
10.3 Merck & Co.
10.3.1 Merck & Co. Corporation Information
10.3.2 Merck & Co. Introduction and Business Overview
10.3.3 Merck & Co. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.3.4 Merck & Co. Anti-Infective Vaccines Products Offered
10.3.5 Merck & Co. Recent Development
10.4 MedImmune LLC
10.4.1 MedImmune LLC Corporation Information
10.4.2 MedImmune LLC Introduction and Business Overview
10.4.3 MedImmune LLC Anti-Infective Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.4.4 MedImmune LLC Anti-Infective Vaccines Products Offered
10.4.5 MedImmune LLC Recent Development
10.5 Novartis Vaccines
10.5.1 Novartis Vaccines Corporation Information
10.5.2 Novartis Vaccines Introduction and Business Overview
10.5.3 Novartis Vaccines Anti-Infective Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.5.4 Novartis Vaccines Anti-Infective Vaccines Products Offered
10.5.5 Novartis Vaccines Recent Development
10.6 Diagnostics Ltd.
10.6.1 Diagnostics Ltd. Corporation Information
10.6.2 Diagnostics Ltd. Introduction and Business Overview
10.6.3 Diagnostics Ltd. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.6.4 Diagnostics Ltd. Anti-Infective Vaccines Products Offered
10.6.5 Diagnostics Ltd. Recent Development
10.7 Intercell Biomedical
10.7.1 Intercell Biomedical Corporation Information
10.7.2 Intercell Biomedical Introduction and Business Overview
10.7.3 Intercell Biomedical Anti-Infective Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.7.4 Intercell Biomedical Anti-Infective Vaccines Products Offered
10.7.5 Intercell Biomedical Recent Development
10.8 MassBiologics
10.8.1 MassBiologics Corporation Information
10.8.2 MassBiologics Introduction and Business Overview
10.8.3 MassBiologics Anti-Infective Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.8.4 MassBiologics Anti-Infective Vaccines Products Offered
10.8.5 MassBiologics Recent Development
10.9 Barr Labs, Inc.
10.9.1 Barr Labs, Inc. Corporation Information
10.9.2 Barr Labs, Inc. Introduction and Business Overview
10.9.3 Barr Labs, Inc. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.9.4 Barr Labs, Inc. Anti-Infective Vaccines Products Offered
10.9.5 Barr Labs, Inc. Recent Development
10.10 Organon Teknika Co.
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Anti-Infective Vaccines Product Category, Application and Specification
10.10.3 Organon Teknika Co. Anti-Infective Vaccines Sales, Revenue, Price and Gross Margin (2016-2021)
10.10.4 Main Business Overview
10.10.5 Organon Teknika Co. Recent Development
10.11 GlaxoSmithKline Biologicals
10.11.1 GlaxoSmithKline Biologicals Corporation Information
10.11.2 GlaxoSmithKline Biologicals Introduction and Business Overview
10.11.3 GlaxoSmithKline Biologicals Anti-Infective Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.11.4 GlaxoSmithKline Biologicals Anti-Infective Vaccines Products Offered
10.11.5 GlaxoSmithKline Biologicals Recent Development
10.12 CSL Ltd.
10.12.1 CSL Ltd. Corporation Information
10.12.2 CSL Ltd. Introduction and Business Overview
10.12.3 CSL Ltd. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.12.4 CSL Ltd. Anti-Infective Vaccines Products Offered
10.12.5 CSL Ltd. Recent Development
10.13 ID Biomedical Co.
10.13.1 ID Biomedical Co. Corporation Information
10.13.2 ID Biomedical Co. Introduction and Business Overview
10.13.3 ID Biomedical Co. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.13.4 ID Biomedical Co. Anti-Infective Vaccines Products Offered
10.13.5 ID Biomedical Co. Recent Development
10.14 Protein Sciences Co.
10.14.1 Protein Sciences Co. Corporation Information
10.14.2 Protein Sciences Co. Introduction and Business Overview
10.14.3 Protein Sciences Co. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.14.4 Protein Sciences Co. Anti-Infective Vaccines Products Offered
10.14.5 Protein Sciences Co. Recent Development
10.15 Wyeth Pharmaceuticals, Inc.
10.15.1 Wyeth Pharmaceuticals, Inc. Corporation Information
10.15.2 Wyeth Pharmaceuticals, Inc. Introduction and Business Overview
10.15.3 Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.15.4 Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Products Offered
10.15.5 Wyeth Pharmaceuticals, Inc. Recent Development
10.16 Berna Biotech
10.16.1 Berna Biotech Corporation Information
10.16.2 Berna Biotech Introduction and Business Overview
10.16.3 Berna Biotech Anti-Infective Vaccines Sales, Revenue and Gross Margin (2016-2021)
10.16.4 Berna Biotech Anti-Infective Vaccines Products Offered
10.16.5 Berna Biotech Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Anti-Infective Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Anti-Infective Vaccines Industrial Chain Analysis
11.4 Anti-Infective Vaccines Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Anti-Infective Vaccines Distributors
12.3 Anti-Infective Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
THE FINAL REPORT WILL COVER THE IMPACT ANALYSIS OF COVID-19, DOWNLOAD FULL STUDY REPORT@ https://www.amecoresearch.com/buy/271736
Unit1, 26 Cleveland Road, South Woodford, London, E182AN, United Kingdom
Contact: (+44) 2032861546
ABOUT US
The complete information about our alliance publishers and the business verticals they cater to helps us in appropriately responding to our client requirements and identifying the potential opportunities in the market and suggest the research that can best suit client's requirement. Our comprehensive list of research reports boasts a complete collection of database casing almost every market category and sub-category.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Anti-Infective Vaccines Market Growth, Trends, Share, COVID-19 Analysis and Forecast 2021-2028 here
News-ID: 2363132 • Views: …
More Releases from Ameco Research
Automotive Relay Market Trend, Size and Forecast till 2030
According to Ameco Research 'Automotive Relay Market report, the analysts took this into account when estimating the Automotive Relay Market size and CAGR for the respective industry. The report's author has thoroughly examined the market and concluded that the Automotive Relay Market 's growth will level off in the coming years. In addition to that, the prominent qualitative information added in the report includes Automotive Relay Market trends, segmentation, key…
Gas Engines Market Size, Forecast till 2030
According to Ameco Research 'Gas Engines Market report, the analysts took this into account when estimating the Gas Engines Market size and CAGR for the respective industry. The report's author has thoroughly examined the market and concluded that the Gas Engines Market 's growth will level off in the coming years. In addition to that, the prominent qualitative information added in the report includes Gas Engines Market trends, segmentation, key…
Simulator Market Growth, Forecast till 2030
According to Ameco Research 'Simulator Market report, the analysts took this into account when estimating the Simulator Market size and CAGR for the respective industry. The report's author has thoroughly examined the market and concluded that the Simulator Market 's growth will level off in the coming years. In addition to that, the prominent qualitative information added in the report includes Simulator Market trends, segmentation, key companies, SWOT, PORTER and…
Alternator Market Regulation Analysis Forecast till 2030
According to Ameco Research 'Alternator Market report, the analysts took this into account when estimating the Alternator Market size and CAGR for the respective industry. The report's author has thoroughly examined the market and concluded that the Alternator Market 's growth will level off in the coming years. In addition to that, the prominent qualitative information added in the report includes Alternator Market trends, segmentation, key companies, SWOT, PORTER and…
More Releases for Vaccines
Vaccines Market: Information by Type (Monovalent Vaccines, Multivalent Vaccines) …
Till date, vaccines have majorly contributed to eradicating several severe diseases—smallpox and polio—from the face of the earth. During 1980–90, around millions of people died due to smallpox. Moreover, after the introduction of a worldwide End Polio Campaign, the number of polio cases has reduced to 407 in 2013 from 350,000 in 1988, the CDC.
Global vaccines market was valued at USD 30.2 billion in 2018 and is expected to…
Global Pet Vaccine Market By Type (Attenuated Live Vaccines, Conjugate Vaccines, …
The Global Pet Vaccine Market 2020 report implement in-depth research of the industry with a focus on the current market trends future prospects. The Global Pet Vaccine Market report aims to provide an overview of Pet Vaccine Market players with detailed market segmentation by product, application and geographical region. It also provides market share and size, revenue forecast, growth opportunity. The most recent trending report Worldwide Pet Vaccine Market Economy…
Animal Vaccines Market Report 2018: Segmentation by Product (Attenuated Vaccines …
Global Animal Vaccines market research report provides company profile for Merck & Co., Inc., Zoetis Inc., Ceva Sant Animale, Sanofi S.A., Romvac, Vaxxinova, Biovac, Merial, Anicon Labor GmbH, Nexvet, PHL Associates, Inc., Hygieia Biological Laboratories, Colorado Serum Company, Pfizer, Arko Laboratories, Ltd. Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in…
Vaccines & Vaccination Market Report 2018: Segmentation by Type (Subunit vaccine …
Global Vaccines & Vaccination market research report provides company profile for CSL, Emergent BioSolutions, GSK, Johnson & Johnson, Pfizer, Merck, Sanofi, Abbott, AstraZeneca, Bavarian Nordic, Novartis, Bharat Biotech, Bio-Med and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year…
Global Veterinary Vaccines Market by Type - Livestock Vaccines and Companion Vac …
According to the report Global Veterinary Vaccines market, published by Market Data Forecast, The Global market has been estimated at USD 5507.3 Million in 2015 and is projected to reach USD 7197.82 Million by 2020, at a CAGR of 5.5% during the forecast period from 2015 to 2020. The Global veterinary vaccines market has seen significant growth over the past few years, due to fear of imminent epidemics that have…
Global Veterinary Vaccines Market, By Technology Type (Inactivated Vaccines, Tox …
Veterinary/Animal Vaccines – Ensure good health of human’s best friends
Veterinary vaccination enhances the health of animals, thus improving their life expectancies. Most common veterinary vaccines include those for rabies, E. coli, distemper, hepatitis rotavirus, parvovirus, brucellosis, and pinkeye. Various diseases such as foot-and-mouth disease and influenza adversely affect livestock across the globe. Economic losses due to death of livestock is significant as it impacts the supply of dairy products, meat,…
